Oral cavity complications of bone marrow transplantation

被引:32
作者
Eisen, D
Essell, J
Broun, ER
机构
关键词
D O I
10.1016/S1085-5629(97)80015-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Bone marrow transplantation, once regarded as experimental, has evolved into a standard treatment for a variety of malignancies, Considerable advances have been made in histocompatibility typing, pretransplantation chemotherapy, and posttransplantation immunosuppressive therapy as well as prophylaxis and treatment of infections, Oral complications develop in almost all patients, and their early recognition may result in the institution of prompt treatment and prolonged survival, Mucositis, often severe and extremely painful, develops in more than three quarters of bone marrow transplant recipients, and its prevention, unfortunately, remains unsatisfactory, Herpes simplex virus and Candida albicans account for most oral infections, although their incidence has been dramatically reduced by the institution of prophylactic agents, Graft versus host disease continues to be a significant complication of marrow transplantation, and the detection of commonly occurring oral changes may support its diagnosis.
引用
收藏
页码:265 / 272
页数:8
相关论文
共 50 条
[11]  
EPSTEIN JB, 1994, BONE MARROW TRANSPL, V13, P81
[12]  
FERRETTI G A, 1990, NCI (National Cancer Institute) Monographs, P51
[13]   SURVEILLANCE OF ORAL CULTURES FOR ENTEROBACTERIACEAE DURING BONE-MARROW TRANSPLANTATION [J].
GALILI, D ;
TAGGER, N ;
SELA, MN ;
GARFUNKEL, AA .
ORAL ONCOLOGY-EUROPEAN JOURNAL OF CANCER PART B, 1995, 31B (01) :58-62
[14]  
GARFUNKEL AA, 1994, ISRAEL J MED SCI, V30, P120
[15]  
GATSONJOHANANSS.F, 1992, ONCOL NURS FORUM, V19, P41
[16]   ORAL ACYCLOVIR PROPHYLACTIC TREATMENT OF HERPES-SIMPLEX INFECTION AFTER BONE-MARROW TRANSPLANTATION [J].
GLUCKMAN, E ;
LOTSBERG, J ;
DEVERGIE, A ;
ZHAO, XM ;
MELO, R ;
GOMEZMORALES, M ;
MAZERON, MC ;
PEROL, Y .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 :161-167
[17]   A CONTROLLED TRIAL OF FLUCONAZOLE TO PREVENT FUNGAL-INFECTIONS IN PATIENTS UNDERGOING BONE-MARROW TRANSPLANTATION [J].
GOODMAN, JL ;
WINSTON, DJ ;
GREENFIELD, RA ;
CHANDRASEKAR, PH ;
FOX, B ;
KAIZER, H ;
SHADDUCK, RK ;
SHEA, TC ;
STIFF, P ;
FRIEDMAN, DJ ;
POWDERLY, WG ;
SILBER, JL ;
HOROWITZ, H ;
LICHTIN, A ;
WOLFF, SN ;
MANGAN, KF ;
SILVER, SM ;
WEISDORF, D ;
HO, WG ;
GILBERT, G ;
BUELL, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (13) :845-851
[18]   THE ORAL CAVITY AS A PORT OF ENTRY FOR EARLY INFECTIONS IN PATIENTS TREATED WITH BONE-MARROW TRANSPLANTATION [J].
HEIMDAHL, A ;
MATTSSON, T ;
DAHLLOF, G ;
LONNQUIST, B ;
RINGDEN, O .
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 1989, 68 (06) :711-716
[19]   EVALUATION OF THE ACCURACY OF A PHARMACOKINETICALLY-BASED PATIENT-CONTROLLED ANALGESIA SYSTEM [J].
HILL, H ;
MACKIE, A ;
CODA, B ;
SCHAFFER, R ;
JACOBSON, R ;
BENEDETTI, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 43 (01) :67-75
[20]  
HILL HF, 1991, CANCER-AM CANCER SOC, V67, P873, DOI 10.1002/1097-0142(19910215)67:4<873::AID-CNCR2820670403>3.0.CO